Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of Priming the Infusion System on the Performance of Target-controlled Infusion of Remifentanil

This study has been completed.
Information provided by (Responsible Party):
Jong Yeop Kim, Ajou University School of Medicine Identifier:
First received: November 14, 2011
Last updated: November 22, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)